Literature DB >> 27793880

MicroRNAs: A Puzzling Tool in Cancer Diagnostics and Therapy.

Barbara D'Angelo1, Elisabetta Benedetti2, Annamaria Cimini3,2,4, Antonio Giordano1,5.   

Abstract

MicroRNAs (miRNAs) constitute a dominating class of small RNAs that regulate diverse cellular functions. Due the pivotal role of miRNAs in biological processes, a deregulated miRNA expression is likely involved in human cancers. MicroRNAs possess tumor suppressor capability, as well as display oncogenic characteristics. Interestingly, miRNAs exist in various biological fluids as circulating entities. Changes in the profile of circulating miRNAs are indicative of pathophysiological conditions in human cancer. This concept has led to consider circulating miRNAs valid biomarkers in cancer diagnostics. Furthermore, current research promotes the use of miRNAs as a target in cancer therapy. However, miRNAs are an evolving research field. Although miRNAs have been demonstrated to be potentially valuable tools both in cancer diagnosis and treatment, a greater effort should be made to improve our understanding of miRNAs biology. This review describes the biology of microRNAs, emphasizing on the use of miRNAs in cancer diagnostics and therapy. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  MicroRNAs; cancer; circulating microRNAs; review

Mesh:

Substances:

Year:  2016        PMID: 27793880     DOI: 10.21873/anticanres.11142

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  39 in total

1.  Altered microRNA expression patterns during the initiation and promotion stages of neonatal diethylstilbestrol-induced dysplasia/neoplasia in the hamster (Mesocricetus auratus) uterus.

Authors:  Ramesh Padmanabhan; Isabel R Hendry; Jennifer R Knapp; Bin Shuai; William J Hendry
Journal:  Cell Biol Toxicol       Date:  2017-03-06       Impact factor: 6.691

Review 2.  Novel Biomarkers for Pancreatic Cysts.

Authors:  Harkirat Singh; Kevin McGrath; Aatur D Singhi
Journal:  Dig Dis Sci       Date:  2017-02-14       Impact factor: 3.199

3.  ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6.

Authors:  Yang Li; An Jiang
Journal:  Cancer Biol Ther       Date:  2020-05-18       Impact factor: 4.742

4.  Post-transcriptional Regulation of MMP16 and TIMP2 Expression via miR-382, miR-410 and miR-200b in Endometrial Cancer.

Authors:  Beata Rak; Dawid Mehlich; Filip Garbicz; Zofia Domosud; Wiktor Paskal; Janina M Marczewska; Paweł K Włodarski
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

5.  MicroRNA-503 serves an oncogenic role in retinoblastoma progression by directly targeting PTPN12.

Authors:  Yang Cheng; Wei Liu
Journal:  Exp Ther Med       Date:  2019-07-19       Impact factor: 2.447

6.  High cripto-1 and low miR-205 expression levels as prognostic markers in early stage non-small cell lung cancer.

Authors:  Kang-Seo Park; Yong Wha Moon; Mark Raffeld; Dae Ho Lee; Yisong Wang; Giuseppe Giaccone
Journal:  Lung Cancer       Date:  2017-12-15       Impact factor: 5.705

7.  Identification of core miRNA prognostic markers in patients with laryngeal cancer using bioinformatics analysis.

Authors:  Guan-Jiang Huang; Bei-Bei Yang
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-12       Impact factor: 2.503

8.  LncRNA SOX2-OT regulates miR-192-5p/RAB2A axis and ERK pathway to promote glioblastoma cell growth.

Authors:  Hongcai Wang; Qinglei Hu; Yilei Tong; Shiwei Li; Maosong Chen; Boding Wang; Haimeng Li
Journal:  Cell Cycle       Date:  2021-09-01       Impact factor: 5.173

9.  Combined microRNA and mRNA microfluidic TaqMan array cards for the diagnosis of malignancy of multiple types of pancreatico-biliary tumors in fine-needle aspiration material.

Authors:  Thomas M Gress; Ludwig Lausser; Lyn-Rouven Schirra; Hans A Kestler; Malte Buchholz; Lisa Ortmüller; Ramona Diels; Bo Kong; Christoph W Michalski; Thilo Hackert; Oliver Strobel; Nathalia A Giese; Miriam Schenk; Rita T Lawlor; Aldo Scarpa
Journal:  Oncotarget       Date:  2017-11-21

10.  Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations.

Authors:  Yunhui Xiang; Liuyun Zhang; Pinpin Xiang; Juan Zhang
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.